l-DOPA and Its Receptor GPR143: Implications for Pathogenesis and Therapy in Parkinson’s Disease

l-3,4-Dihydroxyphenylalanine (l-DOPA) is the most effective therapeutic agent for Parkinson’s disease (PD). l-DOPA is traditionally believed to be an inert amino acid that exerts actions and effectiveness in PD through its conversion to dopamine. In contrast to this generally accepted idea, l-DOPA i...

Descripción completa

Detalles Bibliográficos
Autores principales: Goshima, Yoshio, Masukawa, Daiki, Kasahara, Yuka, Hashimoto, Tatsuo, Aladeokin, Aderemi Caleb
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6785630/
https://www.ncbi.nlm.nih.gov/pubmed/31632270
http://dx.doi.org/10.3389/fphar.2019.01119

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6785630/
https://www.ncbi.nlm.nih.gov/pubmed/31632270
http://dx.doi.org/10.3389/fphar.2019.01119

Ejemplares similares